Orbimed Advisors Llc - Apr 29, 2025 SCHEDULE 13D/A Report for Corvus Pharmaceuticals, Inc. Common stock (CRVS)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
ORBIMED ADVISORS LLC
Security
Corvus Pharmaceuticals, Inc. Common stock
Symbol
CRVS
Shares outstanding
70.9M shares
Disclosed Ownership
9.79M shares
Ownership
13.8%
Form type
SCHEDULE 13D/A
Date filed
5/1/2025, 09:20 PM
Date of event
Apr 29, 2025
Next filing
May 14, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ORBIMED ADVISORS LLC 13.8% 9.79M 0 9.79M /s/ Carl L. Gordon Carl L. Gordon/Member 0001055951
ORBIMED CAPITAL GP V LLC 13.8% 9.79M 0 9.79M /s/ Carl L. Gordon Carl L. Gordon/Member of OrbiMed Advisors LLC 0001615374